Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3018% above fair value
$372.46+1.98 (+0.53%)
Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%
Labcorp ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Labcorp's ebitda for the twelve months ending Sep 30, 2026 was $2.21B, up 9.8% year over year. For fiscal 2025 it was $2.07B, up 19.4% from the year before. Over ten years it grew 3.6% a year on average. The highest annual figure on record is $3.63B in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | +19.4% |
| FY2024 | Dec 31, 2024 | $1.73B | +32.8% |
| FY2023 | Dec 31, 2023 | $1.30B | -34.0% |
| FY2022 | Dec 31, 2022 | $1.97B | -45.6% |
| FY2021 | Dec 31, 2021 | $3.63B | +18.1% |
| FY2020 | Dec 31, 2020 | $3.07B | +61.0% |
| FY2019 | Dec 31, 2019 | $1.91B | +1.6% |
| FY2018 | Dec 31, 2018 | $1.88B | +2.1% |
| FY2017 | Dec 31, 2017 | $1.84B | +3.9% |
| FY2016 | Dec 31, 2016 | $1.77B | +21.7% |
| FY2015 | Dec 31, 2015 | $1.45B | +25.8% |
| FY2014 | Dec 31, 2014 | $1.16B | -5.3% |
| FY2013 | Dec 31, 2013 | $1.22B | -2.6% |
| FY2012 | Dec 31, 2012 | $1.25B | +6.2% |
| FY2011 | Dec 31, 2011 | $1.18B | -0.2% |
| FY2010 | Dec 31, 2010 | $1.18B | +4.5% |
| FY2009 | Dec 31, 2009 | $1.13B | +10.6% |
| FY2008 | Dec 31, 2008 | $1.02B | +8.8% |
| FY2007 | Dec 31, 2007 | $939.80M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $585.10M | +3.1% |
| Q2 FY2026 | Jun 30, 2026 | $630.60M | +11.7% |
| Q1 FY2026 | Mar 31, 2026 | $554.10M | +12.4% |
| Q4 FY2025 | Dec 31, 2025 | $440.60M | +13.8% |
| Q3 FY2025 | Sep 30, 2025 | $567.60M | +36.6% |
| Q2 FY2025 | Jun 30, 2025 | $564.80M | +25.0% |
| Q1 FY2025 | Mar 31, 2025 | $492.80M | +3.6% |
| Q4 FY2024 | Dec 31, 2024 | $387.10M | +1540.3% |
| Q3 FY2024 | Sep 30, 2024 | $415.60M | +4.4% |
| Q2 FY2024 | Jun 30, 2024 | $451.70M | +10.4% |
| Q1 FY2024 | Mar 31, 2024 | $475.80M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | $23.60M | -85.1% |
| Q3 FY2023 | Sep 30, 2023 | $398.20M | -21.6% |
| Q2 FY2023 | Jun 30, 2023 | $409.20M | -24.2% |
| Q1 FY2023 | Mar 31, 2023 | $471.90M | -44.4% |
| Q4 FY2022 | Dec 31, 2022 | $158.90M | -70.6% |
| Q3 FY2022 | Sep 30, 2022 | $508.10M | -46.7% |
| Q2 FY2022 | Jun 30, 2022 | $540.00M | -39.4% |
| Q1 FY2022 | Mar 31, 2022 | $849.40M | -31.6% |
| Q4 FY2021 | Dec 31, 2021 | $539.60M | -63.5% |
| Q3 FY2021 | Sep 30, 2021 | $953.00M | -20.5% |
| Q2 FY2021 | Jun 30, 2021 | $891.20M | +101.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.24B | – |
| Q4 FY2020 | Dec 31, 2020 | $1.48B | +200.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.20B | +147.7% |
| Q2 FY2020 | Jun 30, 2020 | $441.60M | -7.5% |
| Q1 FY2020 | Mar 31, 2020 | -$48.00M | -110.6% |
| Q4 FY2019 | Dec 31, 2019 | $492.20M | +10.5% |
| Q3 FY2019 | Sep 30, 2019 | $484.20M | +1.6% |
| Q2 FY2019 | Jun 30, 2019 | $477.30M | -6.0% |
| Q1 FY2019 | Mar 31, 2019 | $453.70M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | $445.40M | -6.3% |
| Q3 FY2018 | Sep 30, 2018 | $476.50M | +3.6% |
| Q2 FY2018 | Jun 30, 2018 | $507.70M | +11.1% |
| Q1 FY2018 | Mar 31, 2018 | $448.20M | +0.4% |
| Q4 FY2017 | Dec 31, 2017 | $475.60M | +15.5% |
| Q3 FY2017 | Sep 30, 2017 | $459.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $456.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $446.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $411.90M | – |
See a number that looks wrong?